GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Other Current Liabilities

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Other Current Liabilities

: $0.00 Mil (As of Jun. 2023)
View and export this data going back to 2021. Start your Free Trial

Regencell Bioscience Holdings's other current liabilities for the quarter that ended in Jun. 2023 was $0.00 Mil.


Regencell Bioscience Holdings Other Current Liabilities Historical Data

The historical data trend for Regencell Bioscience Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - )
Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Other Current Liabilities
- - - - -

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Current Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Regencell Bioscience Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Regencell Bioscience Holdings Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Headlines

From GuruFocus